CHANGSHENG BIO-TECHNOLOGY CO LTD |
End-of-day quote
Other stock markets
|
||
| - CNY | - |
|
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2016 | 1.02B 141M | Sales 2017 | 1.55B 215M | Capitalization | 14B 1.94B |
|---|---|---|---|---|---|
| Net income 2016 | 425M 58.77M | Net income 2017 | 566M 78.26M | EV / Sales 2016 | 14.2 x |
| Net cash position 2016 | 2.36B 326M | Net cash position 2017 | 2.31B 320M | EV / Sales 2017 | 7.52 x |
| P/E ratio 2016 |
39.5
x | P/E ratio 2017 |
24.7
x | Employees | - |
| Yield 2016 |
1.73% | Yield 2017 |
2.78% | Free-Float | 31.27% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Hong Quan Lu
CEO | Chief Executive Officer | 45 | 21-05-20 |
Chi Wu Chen
CTO | Chief Tech/Sci/R&D Officer | 59 | 08-12-31 |
Xiang Ming Wang
BRD | Director/Board Member | 52 | 93-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ji Ti Liu
BRD | Director/Board Member | 68 | 09-12-31 |
Xiang Ming Wang
BRD | Director/Board Member | 52 | 93-12-31 |
Hong Quan Lu
CEO | Chief Executive Officer | 45 | 21-05-20 |
Changsheng Bio-technology Co., Ltd., formerly Lianyungang Huanghai Machinery Co., Ltd., is a China-based company principally engaged in the research, development, production and sale of human vaccine products. The Company's main products include live attenuated freeze-dried varicella vaccine, freeze-dried human rabies vaccine (Vero cells), freeze-dried live attenuated hepatitis A vaccine, influenza lysis vaccine, adsorption of cell-free diphtheria combined vaccine and ACYW Group 135 meningococcal polysaccharide vaccine. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 106M | |
| -2.35% | 89.08B | |
| +2.76% | 40.9B | |
| -13.45% | 32.25B | |
| +54.69% | 25.14B | |
| -16.16% | 15.39B | |
| -8.97% | 11.91B | |
| -42.60% | 11.89B | |
| -12.82% | 11.64B | |
| +7.34% | 9.03B |
- Stock Market
- Equities
- 002680 Stock